Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > mdjbrown...I don't understand "mystery partner named as
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(549)
•••
Comment by mdjbrownon Apr 05, 2024 3:03pm
48 Views
Post# 35973578

RE:RE:RE:mdjbrown...I don't understand "mystery partner named as

RE:RE:RE:mdjbrown...I don't understand "mystery partner named as you could be right s1i. 

Teva appears to be the first defendant to file an ANDA with the FDA in the fall of 2022, if ANDA numbers are issued in numerical order when they are received by the FDA.

Teva filed ANDA No. 217508
API Pharma filed ANDA No. 217522
Padagis filed ANDA No. 215865   (assume this is a misprint and should state 217865)
Apotex filed ANDA No. 217699
Lupin filed ANDA No. 217871
Biophore and Zenara filed ANDA No. 217910
MSN filed ANDA No. 217911
Taro filed ANDA No. 217930
Alkem filed ANDA No. 217977
Ascent filed ANDA No. 217994

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities